Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy
Information source: Shaheed Beheshti Medical University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Non Arthritic Anterior Ischemic Optic Neuropathy
Intervention: optic nerve neurotomy (Procedure)
Phase: Phase 1/Phase 2
Status: Completed
Sponsored by: Shaheed Beheshti Medical University Official(s) and/or principal investigator(s):
Masoud Soheilian, MD, Principal Investigator, Affiliation: Ophthalmic Research Center of Shaheed Beheshti Medical University
Summary
Non-arthritic anterior ischemic optic neuropathy is the most common cause of sudden visual
loss due to optic nerve involvement in patients above 50 years old. As this problem can be
considered as a sclera out let syndrome an there is no effective and successful treatment for
it, we decided to do a neurotomy procedure and relax the involved optic nerve in order to
achieve acceptable treating outcome.
Clinical Details
Study design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Minimum age: 50 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with non-arthritic anterior ischemic optic nerve
Exclusion Criteria:
- Visual acuity more than 20/200
- Other intra occular operations
- Passing more than 4 weeks of the problem
- Arthritic anterior ischemic optic nerve
- Age under 50 years
- Consumption of previous pharmaceutical treatment
Locations and Contacts
Ophthalmic Research Center, Tehran 16666, Iran, Islamic Republic of
Additional Information
Starting date: January 2003
Last updated: October 11, 2006
|
